|
|
Volumn 35, Issue 4, 2008, Pages 434-437
|
|
Advances in reducing the burden of vascular disease in type 2 diabetes
|
|
Author keywords
ADVANCE; All cause mortality; Blood pressure lowering; Cardiovascular deaths; Microalbuminuria; Perindopril indapamide fixed combination; Total coronary events; Total macrovascular and microvascular disease; Total renal events; Type 2 diabetes
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIHYPERTENSIVE AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLICLAZIDE;
GLUCOSE;
INDAPAMIDE PLUS PERINDOPRIL;
INSULIN;
STATINE DERIVATIVE;
UNCLASSIFIED DRUG;
BLOOD PRESSURE;
CAUSE OF DEATH;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORONARY ARTERY DISEASE;
DIABETIC PATIENT;
DISABILITY;
EPIDEMIC;
HUMAN;
HYPERTENSION;
KIDNEY DISEASE;
MICROALBUMINURIA;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
TABLET;
TREATMENT OUTCOME;
VASCULAR DISEASE;
WORLD HEALTH ORGANIZATION;
ANTIHYPERTENSIVE AGENTS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPERTENSION;
HYPOGLYCEMIC AGENTS;
INDAPAMIDE;
MIDDLE AGED;
PERINDOPRIL;
|
|
EID: 40149099607
PISSN: 03051870
EISSN: 14401681
Source Type: Journal
DOI: 10.1111/j.1440-1681.2008.04892.x Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (12)
|
